🇺🇸 FDA
Patent

US 11219608

Triple combination formulation for treatment of chronic pain

granted A61KA61K31/167A61K45/06

Quick answer

US patent 11219608 (Triple combination formulation for treatment of chronic pain) held by Northwestern University expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/167, A61K45/06, A61K47/10, A61K47/40